Literature DB >> 26367854

Quantitative Targeted Absolute Proteomics for 28 Transporters in Brush-Border and Basolateral Membrane Fractions of Rat Kidney.

Yasuo Uchida1, Takafumi Toyohara2, Sumio Ohtsuki3, Yoshinori Moriyama4, Takaaki Abe5, Tetsuya Terasaki6.   

Abstract

The purpose of the present study was to determine the absolute protein expression levels of various transporters in renal brush-border membrane (BBM) and basolateral membrane (BLM) fractions, in order to understand the quantitative differences in average transport activities among different transporters at each cellular membrane. BBM and BLM fractions of rat kidney were prepared and digested with trypsin, and simultaneous absolute quantification of 28 transporters and a BLM marker, Na(+)/K(+)-ATPase, was performed using our established quantitative-targeted absolute proteomics (QTAP) technique. In BBM fraction, the protein expression levels of bcrp, urat1, mate1, octl1, mrp4, mdr1a, and abca3 were 40.3, 22.2, 8.90, 4.85, 4.69, 3.22, and 0.976 fmol/μg protein, respectively. In BLM fraction, the protein expression levels of oat1, oat3, oct1, mrp6, and mrp1 were 10.6, 10.2, 4.59, 0.724, and 0.271 fmol/μg protein, respectively. The expression levels of abca2, abca4, abca5, abca12, abcb4, mrp5, abcc9, abcg1, abcg5, lat1, ntcp, pgt, oatp2b1, oatp1b2, oatp3a1, and oct3 were under the limit of quantification in both fractions. The quantitative transporter protein expression profiles at these membranes, as determined by QTAP analysis, should be helpful to understand the contributions of individual transporters to renal excretion of xenobiotics and endogenous compounds.
Copyright © 2016. Published by Elsevier Inc.

Entities:  

Keywords:  ABC transporters; HPLC (high-performance/pressure liquid chromatography); drug transport; mass spectrometry; membrane transport; membrane transporter; proteins; proteomics; renal excretion; solute transporters

Mesh:

Substances:

Year:  2016        PMID: 26367854     DOI: 10.1002/jps.24645

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  7 in total

1.  Quantification of Four Efflux Drug Transporters in Liver and Kidney Across Species Using Targeted Quantitative Proteomics by Isotope Dilution NanoLC-MS/MS.

Authors:  John K Fallon; Philip C Smith; Cindy Q Xia; Mi-Sook Kim
Journal:  Pharm Res       Date:  2016-06-29       Impact factor: 4.200

2.  Multimodal analysis of drug transporter expression in gastrointestinal tissue.

Authors:  Corbin G Thompson; John K Fallon; Michelle Mathews; Paige Charlins; Leila Remling-Mulder; Martina Kovarova; Lourdes Adamson; Nithya Srinivas; Amanda Schauer; Craig Sykes; Paul Luciw; J Victor Garcia; Ramesh Akkina; Philip C Smith; Angela D M Kashuba
Journal:  AIDS       Date:  2017-07-31       Impact factor: 4.177

Review 3.  Key to Opening Kidney for In Vitro-In Vivo Extrapolation Entrance in Health and Disease: Part I: In Vitro Systems and Physiological Data.

Authors:  Daniel Scotcher; Christopher Jones; Maria Posada; Amin Rostami-Hodjegan; Aleksandra Galetin
Journal:  AAPS J       Date:  2016-06-30       Impact factor: 4.009

4.  Comparison of Hepatic Transporter Tissue Expression in Rodents and Interspecies Hepatic OCT1 Activity.

Authors:  Bridget L Morse; John K Fallon; Anil Kolur; Andrew T Hogan; Philip C Smith; Kathleen M Hillgren
Journal:  AAPS J       Date:  2021-04-26       Impact factor: 4.009

5.  The Promises of Quantitative Proteomics in Precision Medicine.

Authors:  Bhagwat Prasad; Marc Vrana; Aanchal Mehrotra; Katherine Johnson; Deepak Kumar Bhatt
Journal:  J Pharm Sci       Date:  2016-12-08       Impact factor: 3.534

Review 6.  Using miniature brain implants in rodents for novel drug discovery.

Authors:  Ben Waldau
Journal:  Expert Opin Drug Discov       Date:  2019-03-04       Impact factor: 7.050

7.  Identification of Structural Features for the Inhibition of OAT3-Mediated Uptake of Enalaprilat by Selected Drugs and Flavonoids.

Authors:  Yao Ni; Zelin Duan; Dandan Zhou; Shuai Liu; Huida Wan; Chunshan Gui; Hongjian Zhang
Journal:  Front Pharmacol       Date:  2020-05-28       Impact factor: 5.810

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.